<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Plse see survey below.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Participate if you wish.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Jackie Manthorne [mailto:jmanthorne@survivornet.ca] <br><b>Sent:</b> October 8, 2014 11:59 AM<br><b>To:</b> Jackie Manthorne<br><b>Subject:</b> Participate in our survey about Xtandi!<o:p></o:p></span></p></div><p class=MsoNormal><o:p> </o:p></p><div><div><p class=MsoNormal>Dear Friends,<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>Please take a few moments of your time to participate in our survey about Xtandi and/or send it to friends, colleagues or fellow support group members.<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>The purpose of this survey is to provide the us with insights and perspectives about living with and managing metastatic prostate cancer from patients and caregivers in order to complete a patient evidence submission to the pan-Canadian Oncology Drug Review for enzalutamide (Xtandi) for the treatment of patients with metastatic castration-resistant prostate cancer (mPRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy who have not received prior chemotherapy.<br><br>This survey will be available starting now and remain open until October 13, 5 pm, 2014.<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>To access the survey, go to <a href="https://www.surveymonkey.com/s/JCXNYJH" target="_blank">https://www.surveymonkey.com/s/JCXNYJH</a><br><br>We would like to thank you if you have already completed this survey, and invite those who haven't to participate now!<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>Best,<o:p></o:p></p></div><div><p class=MsoNormal>Jackie<br clear=all><br>-- <o:p></o:p></p></div><div><div><p class=MsoNormal>Jackie Manthorne<o:p></o:p></p></div><div><p class=MsoNormal>President and CEO<o:p></o:p></p></div><div><p class=MsoNormal>Présidente et chef de la direction<o:p></o:p></p></div><div><p class=MsoNormal>Canadian Cancer Survivor Network<o:p></o:p></p></div><div><p class=MsoNormal>Réseau canadien des survivants du cancer<o:p></o:p></p></div><div><p class=MsoNormal>1750 croissant Courtwood Crescent, Suite 210<o:p></o:p></p></div><div><p class=MsoNormal>Otttawa, ON K2C 2B5<o:p></o:p></p></div><div><p class=MsoNormal>Telephone / Téléphone : 613-898-1871<o:p></o:p></p></div><div><p class=MsoNormal>E-mail / Courriel : <a href="mailto:jmanthorne@survivornet.ca" target="_blank">jmanthorne@survivornet.ca</a><o:p></o:p></p></div><div><p class=MsoNormal>Web site / site web: <a href="http://www.survivornet.ca" target="_blank">www.survivornet.ca</a><o:p></o:p></p></div><div><p class=MsoNormal>Blog: <a href="http://jackiemanthornescancerblog.blogspot.com/" target="_blank">http://jackiemanthornescancerblog.blogspot.com/</a><o:p></o:p></p></div><div><p class=MsoNormal>Twitter: @<a href="http://survivornet.ca" target="_blank">survivornet.ca</a><o:p></o:p></p></div></div></div></div></body></html>